Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy todayheadline
Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...
Read moreDetailsBristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...
Read moreDetails
